Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19: A meta-analysis of randomized controlled trials

To evaluate the effectiveness and safety of rivaroxaban anticoagulation in COVID-19 patients. PubMed, Embase, Cochrane Library electronic databases, and ClinicalTrials.gov were searched to identify all relevant randomized controlled trial studies from December 2019 to July 2023. A total of 6 randomi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Saudi medical journal 2024-04, Vol.45 (4), p.341-348
Hauptverfasser:	Shen, Xiangbo, Qiu, Eryue, Liu, Zhao, Zhu, Xiaopeng, Zeng, Yiqian
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - adverse effects Anticoagulants - therapeutic use COVID-19 - complications COVID-19 Drug Treatment Factor Xa Inhibitors - adverse effects Factor Xa Inhibitors - therapeutic use Hemorrhage - chemically induced Heparin - adverse effects Heparin - therapeutic use Heparin, Low-Molecular-Weight - adverse effects Heparin, Low-Molecular-Weight - therapeutic use Humans Randomized Controlled Trials as Topic Rivaroxaban - adverse effects Rivaroxaban - therapeutic use SARS-CoV-2 Systematic Review Thrombosis - etiology Thrombosis - prevention & control Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!